Bacteria News and Research

RSS

UCL-led team develops new technique to find resistant TB faster

The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.

From Oxford Gene Technology 13 May 2015

Australian researchers discover rogue germinal centre B cells that trigger autoimmune disease

Australian researchers believe they have discovered a group of cells that trigger autoimmune disease, as well as the molecular 'trigger guard' that normally holds them in check.

13 May 2015

Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

Over nearly 15 years spent studying ticks, Indiana University's Keith Clay has found southern Indiana to be an oasis free from Lyme disease, the condition most associated with these arachnids that are the second most common parasitic disease vector on Earth.

11 May 2015

LSTM scientists one step closer to understanding why HAP increases risk of pneumonia

Scientists at LSTM have come a step closer to understanding why people exposed to household air pollution (HAP) are at higher risk of lung infections such as pneumonia and tuberculosis.

8 May 2015

Removing bacterial biofilms could help prevent and treat colon cancers, study suggests

A team led by scientists at The Scripps Research Institute and Johns Hopkins University School of Medicine has uncovered a big clue to how bacteria may promote some colon cancers.

8 May 2015

Natural substance could help people avoid cavities, gum disease

Arginine, a common amino acid found naturally in foods, breaks down dental plaque, which could help millions of people avoid cavities and gum disease, researchers at the University of Michigan and Newcastle University have discovered.

8 May 2015

Discovery may have opened up new frontier in fight against breast cancer

For years, scientists have been puzzled by the presence of short stretches of genetic material floating inside a variety of cells, ranging from bacteria to mammals, including humans. These fragments are pieces of the genetic instructions cells use to make proteins, but are too short a length to serve their usual purpose.

8 May 2015

Adelaide researchers identify target for developing new antibiotics against disease-causing bacteria

University of Adelaide researchers have discovered a target for the development of completely new antibiotics against disease-causing bacteria.

7 May 2015

Fecal transplantation cures C. diff infection, eliminates multi-drug resistant pathogens

A fecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both in the patient's gastrointestinal tract, and several other body sites.

7 May 2015

Researchers report novel approach to combat multidrug-resistant bacterial pathogens

With the threat of multidrug-resistant bacterial pathogens growing, new ideas to treat infections are sorely needed. Researchers at University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences report preliminary success testing an entirely novel approach -- tagging bacteria with a molecular "homing beacon" that attracts pre-existing antibodies to attack the pathogens.

7 May 2015

New study shows ulcer-causing bacteria can directly interact with stomach stem cells

The ulcer-causing bacterium Helicobacter pylori can directly interact with stomach stem cells, causing the cells to divide more rapidly, according to a new study by researchers at the Stanford University School of Medicine.

7 May 2015

Medilink UK Awards - The Winners 2015

The best of the UK's Life Sciences and Healthcare Technology sector have been honoured at the 2015 Medilink UK Awards.

6 May 2015

Researcher reports possible existence of sixth DNA base

DNA (deoxyribonucleic acid) is the main component of our genetic material. It is formed by combining four parts: A, C, G and T (adenine, cytosine, guanine and thymine), called bases of DNA combine in thousands of possible sequences to provide the genetic variability that enables the wealth of aspects and functions of living beings.

6 May 2015

Automated PoCyton cytometer effective for counting cancer cells

Biological and medical scientists have been using flow cytometry to count cancer cells for the past 40 years. But the large instruments are expensive and can only be operated by trained personnel. By contrast the PoCyton cytometer developed by Fraunhofer researchers is cheap to produce, no bigger than a shoebox, and automated.

6 May 2015

Lymphatic pump treatment may fight pneumonia by enhancing efficacy of antibiotics

Lymphatic pump treatment (LPT) shows promise in managing pneumonia when combined with antibiotic treatment, according to a new study published in The Journal of the American Osteopathic Association.

5 May 2015

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

Lucideon, the materials technology company, together with 9 European consortium partners, has been awarded €3.9m (£2.8m) grant by the European Commission to train industry PhD researchers for the development of drug-free antibacterial materials used for medical applications, such as wound care and implants.

From Lucideon 5 May 2015

Pneumonic plague transmission from dog to man

Pneumonic plague is a rare but life-threatening condition caused by the bacteria Yersinia pestis. Y pestis is usually carried by rodents and can be transmitted to humans through a bite from an infected rodent or rodent flea or inhalation of infectious droplets...

1 May 2015

New research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D

Eleven IFPMA member companies are involved in the development of new antibiotics. There are currently 34 antibacterial compounds in development (19 molecules and 15 vaccines). Eight compounds are undergoing the final stages of demonstrating their efficacy, quality, and safety (phase 3 clinical trials)...

30 Apr 2015

New research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D

30 Apr 2015

Urine profiles provide clues to how obesity causes disease

Scientists have identified chemical markers in urine associated with body mass, providing insights into how obesity causes disease...

30 Apr 2015

Bacteria News and Research

UCL-led team develops new technique to find resistant TB faster

Australian researchers discover rogue germinal centre B cells that trigger autoimmune disease

Southern Indiana to be oasis free from Lyme disease, finds Indiana University researcher

LSTM scientists one step closer to understanding why HAP increases risk of pneumonia

Removing bacterial biofilms could help prevent and treat colon cancers, study suggests

Natural substance could help people avoid cavities, gum disease

Discovery may have opened up new frontier in fight against breast cancer

Adelaide researchers identify target for developing new antibiotics against disease-causing bacteria

Fecal transplantation cures C. diff infection, eliminates multi-drug resistant pathogens

Researchers report novel approach to combat multidrug-resistant bacterial pathogens

New study shows ulcer-causing bacteria can directly interact with stomach stem cells

Medilink UK Awards - The Winners 2015

Researcher reports possible existence of sixth DNA base

Automated PoCyton cytometer effective for counting cancer cells

Lymphatic pump treatment may fight pneumonia by enhancing efficacy of antibiotics

Lucideon and European partners awarded €3.9m to train industry PhD researchers to develop drug-free antibacterial materials

Pneumonic plague transmission from dog to man

New research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D

New research-based pharmaceutical industry report provides insights on how to slow down antimicrobial resistance (AMR) and boost antibiotic R&D

Urine profiles provide clues to how obesity causes disease

Microbiology eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News